Adav Sunil S, Sze Siu Kwan
Division of Structural Biology and Biochemistry, School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore, 637551, Singapore.
Mol Brain. 2016 Nov 3;9(1):92. doi: 10.1186/s13041-016-0272-9.
Dementia is a syndrome associated with a wide range of clinical features including progressive cognitive decline and patient inability to self-care. Due to rapidly increasing prevalence in aging society, dementia now confers a major economic, social, and healthcare burden throughout the world, and has therefore been identified as a public health priority by the World Health Organization. Previous studies have established dementia as a 'proteinopathy' caused by detrimental changes in brain protein structure and function that promote misfolding, aggregation, and deposition as insoluble amyloid plaques. Despite clear evidence that pathological cognitive decline is associated with degenerative protein modifications (DPMs) arising from spontaneous chemical modifications to amino acid side chains, the molecular mechanisms that promote brain DPMs formation remain poorly understood. However, the technical challenges associated with DPM analysis have recently become tractable due to powerful new proteomic techniques that facilitate detailed analysis of brain tissue damage over time. Recent studies have identified that neurodegenerative diseases are associated with the dysregulation of critical repair enzymes, as well as the misfolding, aggregation and accumulation of modified brain proteins. Future studies will further elucidate the mechanisms underlying dementia pathogenesis via the quantitative profiling of the human brain proteome and associated DPMs in distinct phases and subtypes of disease. This review summarizes recent developments in quantitative proteomic technologies, describes how these techniques have been applied to the study of dementia-linked changes in brain protein structure and function, and briefly outlines how these findings might be translated into novel clinical applications for dementia patients. In this review, only spontaneous protein modifications such as deamidation, oxidation, nitration glycation and carbamylation are reviewed and discussed.
痴呆是一种与广泛临床特征相关的综合征,包括进行性认知衰退和患者无法自理。由于老龄化社会中患病率迅速上升,痴呆如今在全球造成了重大的经济、社会和医疗负担,因此被世界卫生组织确定为公共卫生重点。先前的研究已将痴呆确立为一种“蛋白病”,由脑蛋白结构和功能的有害变化引起,这些变化会促进错误折叠、聚集和沉积为不溶性淀粉样斑块。尽管有明确证据表明病理性认知衰退与氨基酸侧链自发化学修饰产生的退行性蛋白修饰(DPM)有关,但促进脑DPM形成的分子机制仍知之甚少。然而,由于强大的新蛋白质组学技术有助于随时间对脑组织损伤进行详细分析,与DPM分析相关的技术挑战最近已变得易于处理。最近的研究已确定神经退行性疾病与关键修复酶的失调以及修饰脑蛋白的错误折叠、聚集和积累有关。未来的研究将通过对人脑蛋白质组和疾病不同阶段及亚型中相关DPM进行定量分析,进一步阐明痴呆发病机制的潜在机制。本综述总结了定量蛋白质组学技术的最新进展,描述了这些技术如何应用于研究与痴呆相关的脑蛋白结构和功能变化,并简要概述了这些发现如何转化为痴呆患者的新型临床应用。在本综述中,仅对脱酰胺、氧化、硝化、糖基化和氨甲酰化等自发蛋白修饰进行综述和讨论。